Insider · CIK 0001800668

Anders Jack

Reports to the SEC for 1 company · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001800668

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−3,992 sh	$199.30	−$796K	119,216
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−61 sh	$195.00	−$11.9K	123,208
2026-06-24	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+20K sh	$18.56	+$371K	143,269
2026-06-24	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−9,496 sh	$168.20	−$1.6M	129,220
2026-06-24	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−4,553 sh	$167.34	−$762K	138,716
2026-06-24	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−5,651 sh	$169.24	−$956K	123,569
2026-06-24	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−300 sh	$170.32	−$51.1K	123,269
2026-06-24	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+20K sh	—	—	20,600
2026-06-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−2,722 sh	$156.12	−$425K	123,269
2026-03-17	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−2,753 sh	$99.48	−$274K	125,512
2026-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+45.4K sh	—	—	45,400
2026-03-01	RVMDRevolution Medicines, Inc.A Award	Chief Financial Officer	AAward	+20.2K sh	—	—	128,265
2026-01-07	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	15,900
2026-01-07	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$98.00	−$980K	108,065
2026-01-07	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$42.45	+$425K	118,065
2025-12-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−3,104 sh	$77.09	−$239K	108,065
2025-11-25	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,418 sh	$17.00	+$92.1K	116,412
2025-11-25	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,418 sh	—	—	0
2025-11-25	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−5,418 sh	$74.00	−$401K	110,994
2025-11-11	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$17.00	+$170K	120,994
2025-11-11	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	5,418
2025-11-11	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$64.00	−$640K	110,994
2025-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−2,320 sh	$45.82	−$106K	110,994
2025-09-03	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−5,238 sh	$40.17	−$210K	113,314
2025-09-03	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,049 sh	—	—	15,418
2025-09-03	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,189 sh	$4.73	+$15.1K	116,503
2025-09-03	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,049 sh	$17.00	+$34.8K	118,552
2025-09-03	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,189 sh	—	—	0
2025-09-02	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−4,762 sh	$40.02	−$191K	113,314
2025-09-02	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,814 sh	$2.68	+$7,541.52	116,128
2025-09-02	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,948 sh	$4.73	+$9,214.04	118,076
2025-09-02	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,814 sh	—	—	0
2025-09-02	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,948 sh	—	—	3,189
2025-06-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−2,170 sh	$39.83	−$86.4K	113,314
2025-03-17	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−1,864 sh	$39.04	−$72.8K	115,006
2025-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+71.4K sh	—	—	71,400
2025-03-01	RVMDRevolution Medicines, Inc.A Award	Chief Financial Officer	AAward	+20.4K sh	—	—	116,870
2024-12-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−2,635 sh	$45.40	−$120K	96,470
2024-10-11	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$50.30	−$503K	98,932
2024-10-11	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	2,814
2024-10-11	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$2.68	+$26.8K	108,932
2024-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−2,244 sh	$44.19	−$99.2K	98,932
2024-06-17	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−1,893 sh	$37.39	−$70.8K	101,176
2024-05-03	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$2.68	+$26.8K	111,959
2024-05-03	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$40.03	−$400K	101,959
2024-05-03	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	12,814
2024-03-18	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−1,261 sh	$31.58	−$39.8K	101,959
2024-03-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+92.4K sh	—	—	92,400
2024-03-01	RVMDRevolution Medicines, Inc.A Award	Chief Financial Officer	AAward	+26.4K sh	—	—	103,220
2023-12-18	RVMDRevolution Medicines, Inc.S Sale	Chief Financial Officer	SSale	−1,775 sh	$25.90	−$46K	76,416

Recent filings

Accepted (ET)
Sep 184
Anders Jack0001800668-26-000007
SEC(opens sec.gov)
Jun 264
Anders Jack0001610717-26-000296
SEC(opens sec.gov)
Jun 184
Anders Jack0001610717-26-000244
SEC(opens sec.gov)
Mar 194
Anders Jack0001610717-26-000128
SEC(opens sec.gov)
Mar 34
Anders Jack0001610717-26-000079
SEC(opens sec.gov)
Jan 94
Anders Jack0001610717-26-000012
SEC(opens sec.gov)
Dec 184
Anders Jack0001610717-25-000420
SEC(opens sec.gov)
Nov 264
Anders Jack0001610717-25-000404
SEC(opens sec.gov)
Nov 134
Anders Jack0001610717-25-000377
SEC(opens sec.gov)

Companies

Revolution Medicines, Inc.Chief Financial OfficerRVMD

Address

REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE

REDWOOD CITY, CA, 94063